v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2022   96,500,000      
Beginning balance at Dec. 31, 2022 $ 1,707.8 $ 0.1 $ 2,122.4 $ (7.9) $ (406.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 249.7       249.7
Other comprehensive (loss) income, net of tax 14.9     14.9  
Stock-based compensation expense 194.3   194.3    
Issuances of common stock under benefit plans (in shares)   2,200,000      
Issuances of common stock under benefit plans 65.3   65.3    
Ending balance (in shares) at Dec. 31, 2023   98,700,000      
Ending balance at Dec. 31, 2023 2,232.0 $ 0.1 2,382.0 7.0 (157.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 341.3       341.3
Other comprehensive (loss) income, net of tax (1.2)     (1.2)  
Stock-based compensation expense 195.5   195.5    
Issuances of common stock under benefit plans (in shares)   2,700,000      
Issuances of common stock under benefit plans 122.1   122.1    
Repurchases of common stock (in shares)   (2,000,000.0)      
Repurchases of common stock (300.0)   (145.0)   (155.0)
Ending balance (in shares) at Dec. 31, 2024   99,400,000      
Ending balance at Dec. 31, 2024 2,589.7 $ 0.1 2,554.6 5.8 29.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 478.6       478.6
Other comprehensive (loss) income, net of tax 7.3     7.3  
Stock-based compensation expense 217.9   217.9    
Issuances of common stock under benefit plans (in shares)   2,500,000      
Issuances of common stock under benefit plans 127.3   127.3    
Repurchases of common stock (in shares)   (1,800,000)      
Repurchases of common stock (167.7)   (107.6)   (60.1)
Ending balance (in shares) at Dec. 31, 2025   100,100,000      
Ending balance at Dec. 31, 2025 $ 3,253.1 $ 0.1 $ 2,792.2 $ 13.1 $ 447.7